Antimicrobial Agents and Chemotherapy · 2007 · 259 citations · 35 references
Veterinary MedicineMicrobiologyPathologyChemotherapyInflammationMedical MicrobiologyBacterial InfectionsBacterial PathologyGranulomatous InflammationPulmonary TuberculosisTuberculosis PharmacotherapyGuinea Pig ModelsHematogenous DisseminationInflammatory Lung LesionsMycobacterial Granulomatous InflammationMycobacterium Tuberculosis InfectionMycobacterium Tuberculosis PathogenesisTuberculosis In AnimalsTuberculosis Pathology
The lengthy chemotherapy of tuberculosis reflects the ability of a small subpopulation of Mycobacterium tuberculosis bacteria to persist in infected individuals. To date, the exact location of these persisting bacteria is not known. Lung lesions in guinea pigs infected with M. tuberculosis have striking similarities, such as necrosis, mineralization, and hypoxia, to natural infections in humans. Guinea pigs develop necrotic primary lesions after aerosol infection that differ in their morphology compared to secondary lesions resulting from hematogenous dissemination. In infected guinea pigs conventional therapy for tuberculosis during 6 weeks reduced the bacterial load by 1.7 logs in the lungs and, although this completely reversed lung inflammation associated with secondary lesions, the primary granulomas remained largely unaffected. Treatment of animals with the experimental drug R207910 (TMC207) for 6 weeks was highly effective with almost complete eradication of the bacteria throughout both the primary and the secondary lesions. Most importantly, the few remnants of acid-fast bacilli remaining after R207910 treatment were to be found extracellular, in a microenvironment of residual primary lesion necrosis with incomplete dystrophic calcification. This zone of the primary granuloma is hypoxic and is morphologically similar to what has been described for human lung lesions. These results show that this acellular rim may, therefore, be a primary location of persisting bacilli withstanding drug treatment.
35
A Diarylquinoline Drug Active on the ATP Synthase of <i>Mycobacterium tuberculosis</i>
Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · Science · 2004 · 2.2K citations · Full text
Tuberculosis: Pathogenesis, Protection and Control
Nature Medicine · 1996 · 977 citations